These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20150554)
1. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Fiskesund R; Stegmayr B; Hallmans G; Vikström M; Weinehall L; de Faire U; Frostegård J Stroke; 2010 Apr; 41(4):607-12. PubMed ID: 20150554 [TBL] [Abstract][Full Text] [Related]
2. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden. Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878 [TBL] [Abstract][Full Text] [Related]
3. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Sjöberg BG; Su J; Dahlbom I; Grönlund H; Wikström M; Hedblad B; Berglund G; de Faire U; Frostegård J Atherosclerosis; 2009 Apr; 203(2):528-32. PubMed ID: 18809177 [TBL] [Abstract][Full Text] [Related]
4. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against Phosphorylcholine among New Guineans Compared to Swedes: An Aspect of the Hygiene/Missing Old Friends Hypothesis. Frostegård J; Tao W; Råstam L; Lindblad U; Lindeberg S Immunol Invest; 2017 Jan; 46(1):59-69. PubMed ID: 27611006 [TBL] [Abstract][Full Text] [Related]
6. Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development. Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J PLoS One; 2014; 9(12):e111764. PubMed ID: 25473948 [TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project. Ahmed E; Stegmayr B; Trifunovic J; Weinehall L; Hallmans G; Lefvert AK Stroke; 2000 Jun; 31(6):1289-93. PubMed ID: 10835446 [TBL] [Abstract][Full Text] [Related]
8. Low levels of antibodies against phosphorylcholine in Alzheimer's disease. Eriksson UK; Sjöberg BG; Bennet AM; de Faire U; Pedersen NL; Frostegård J J Alzheimers Dis; 2010; 21(2):577-84. PubMed ID: 20571218 [TBL] [Abstract][Full Text] [Related]
9. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls. Lourdudoss C; Ajeganova S; Frostegård J Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894 [TBL] [Abstract][Full Text] [Related]
10. IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome. Knudsen EC; Seljeflot I; Aksnes TA; Eritsland J; Arnesen H; Andersen GØ PLoS One; 2019; 14(4):e0215640. PubMed ID: 31002684 [TBL] [Abstract][Full Text] [Related]
12. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms. Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765 [TBL] [Abstract][Full Text] [Related]
13. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men. Gigante B; Leander K; Vikström M; Baldassarre D; Veglia F; Strawbridge RJ; McLeod O; Gertow K; Sennblad B; Shah S; Zabaneh D; Humphries SE; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; Hamsten A; Frostegård J; de Faire U; Atherosclerosis; 2014 Oct; 236(2):394-9. PubMed ID: 25150937 [TBL] [Abstract][Full Text] [Related]
14. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women. Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890 [TBL] [Abstract][Full Text] [Related]
15. Natural antibodies against phosphorylcholine in cardiovascular disease. de Faire U; Frostegård J Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165 [TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study. Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975 [TBL] [Abstract][Full Text] [Related]
18. Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds. Thiagarajan D; Frostegård AG; Singh S; Rahman M; Liu A; Vikström M; Leander K; Gigante B; Hellenius ML; Zhang B; Zubarev RA; de Faire U; Lundström SL; Frostegård J J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27998914 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study. Ajeganova S; Ehrnfelt C; Alizadeh R; Rohani M; Jogestrand T; Hafström I; Frostegård J Rheumatology (Oxford); 2011 Oct; 50(10):1785-93. PubMed ID: 21743088 [TBL] [Abstract][Full Text] [Related]
20. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegård J Rheumatology (Oxford); 2008 Aug; 47(8):1144-50. PubMed ID: 18522961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]